Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
Many viral fusion proteins exhibit a six-helix bundle as a core structure. HIV Env-induced fusion was studied to resolve whether membrane merger was due to the transition into the bundle configuration or occurred after bundle formation. Suboptimal temperature was used to arrest fusion at an intermediate stage. When bundle formation was prevented by adding inhibitory peptides at this stage, membranes did not merge upon raising temperature. Inversely, when membrane merger was prevented by incorporating lysophosphatidylcholine (LPC) into cell membranes at the intermediate, the bundle did not form upon optimizing temperature. In the absence of LPC, the six-helix bundle did not form when the temperature of the intermediate was raised for times too short to promote fusion. Kinetic measures showed that after the temperature pulse, cells had not advanced further toward fusion. The latter results indicate that bundle formation is the rate-limiting step between the arrested intermediate and fusion. Electrical measures showed that the HIV Env-induced pore is initially large and grows rapidly. It is proposed that bundle formation and fusion are each contingent on the other and that movement of Env during its transition into the six-helix bundle directly induces the lipid rearrangements of membrane fusion. Because peptide inhibition showed that, at the intermediate stage, the heptad repeats of gp41 have become stably exposed, creation of the intermediate could be of importance in drug and/or vaccine development.
Melikyan
G B
GB
Department of Molecular Biophysics and Physiology, Rush Medical College, Chicago, Illinois 60612, USA.
Markosyan
R M
RM
Hemmati
H
H
Delmedico
M K
MK
Lambert
D M
DM
Cohen
F S
FS
D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D015700:HIV Envelope Protein gp41 / Q000737:chemistry* / Q000378:metabolism*; D015497:HIV-1; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008561:Membrane Fusion / Q000187:drug effects; D008954:Models, Biological; D009038:Motion; D011487:Protein Conformation; D019718:Receptors, CXCR4; D013696:Temperature; D013816:Thermodynamics
D015700:HIV Envelope Protein gp41; D008244:Lysophosphatidylcholines; D019718:Receptors, CXCR4